Skip to main content

Fiscal Wizard · Single-issue tearsheet

KVUE / Aug 31, 2026 Run #19045

KVUE

Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Composite verdict

B 71.7 / 100
Bullish setup · Reversal 12 drivers · 3 gates blocking
  • Relative Strength vs SPY
  • Sector Relative Strength
  • Vortex Signal
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 1st of 7 in Household & Personal Products

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 25 signals0% Bear
Momentum Bullish 95Mean-reversion Neutral 51

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -64%
Asset value $5.60Earnings power value $6.82Price $18.93

Priced above its no-growth earnings power value ($6.82/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

43.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Dividend Yield 93
Payout Ratio 0
Forward P/E 75
Revenue Growth (YoY) 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Relative Strength vs SPY, Sector Relative Strength, Vortex Signal); bears gated by guards. · 44 signals shown.

Strongest
Weakest
Relative Strength vs SPY 89
Sector Relative Strength 89
Vortex Signal 89

Risk Gates

3 blocking 8 caution

3 guards active, 16 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for KVUE.